CGM Devices for Longevity Biohacking Reviewed: What the Evidence Actually Shows
Six leading CGM platforms compared on accuracy, evidence quality, and longevity claims โ most fall short of the hype.
56 articles
Six leading CGM platforms compared on accuracy, evidence quality, and longevity claims โ most fall short of the hype.
A comparative review of NMN and NR supplements weighs tissue targeting, clinical evidence, and top-rated products for NAD+ optimization.
Burke and Noakes reach surprising common ground on fueling endurance sport, while key disagreements remain unresolved.
A major Lancet review argues that optimizing current depression treatments may be more impactful than developing new ones.
Continuous glucose monitors are popular in biohacking circles, but direct evidence linking CGM use to extended lifespan remains thin.
A scoping review exposes deep conceptual gaps in how physical resilience is defined and measured across aging and rehabilitation science.
A new review maps the bidirectional crosstalk between gut microbiota and cellular senescence driving multi-organ degeneration.
A Cochrane review finds only one small RCT on surgical timing for cardiac surgery, with afternoon starts linked to lower troponin release.
Expert reviews rank fisetin and quercetin as top senolytics, with spermidine and resveratrol as supporting players in longevity supplement stacks.
A Cochrane meta-analysis of 11 RCTs finds very low-certainty evidence that liver support systems neither reduce mortality nor improve key outcomes in ALF.
Virtual patient replicas built from multimodal data may slash trial costs, generate synthetic control arms, and predict treatment response in IBD.
A Cochrane review of 107 RCTs finds vitamin D may slightly cut ARI-related doctor visits in under-5s, but evidence remains low-certainty.